Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. March 7, 2018. Peter Ellingworth.

Executive Summary

Check out what Association of British Healthcare Industries CEO Peter Ellingworth had to say about the risks of disrupting medtech supply chains with the UK’s pending exit from the EU.

"The nature of supply chains for health tech is such that even goods manufactured in the UK are often ultimately supplied to the [National Health Service] from distribution centers in the EU." –Peter Ellingworth, CEO, Association of British Healthcare Industries

Find out more: UK Medtechs Stress Need To Get It Right On Brexit As Prime Minister Addresses EU 

Click here for a free trial of Medtech Insight

 

Advertisement

Related Content

UK Medtechs Stress Need To Get It Right On Brexit As Prime Minister Addresses EU

Topics

Advertisement
UsernamePublicRestriction

Register

MT122302

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel